OCTOBER 2022LIFE SCIENCES REVIEW6Alarge number of infectious diseases and increasing cases of chronic diseases has been the key factor in the proliferation of the bioanalytical services market. According to MarketWatch, the global bioanalytical testing services market, worth USD 3.5 billion in 2022, is projected to reach USD 6.1 billion in 2027 at a compounding annual growth rate of 12.1 per cent. Several pharmaceutical organizations are collaborating with research institutes to provide efficient, cost-effective bioanalytical services to meet the increase in demand. Healthcare providers are looking to set up labs on-premise and partner with bioanalytical service providers to improve the efficiency of treatments. Furthermore, access to patients' genomic information is also revolutionizing the bioanalytical industry by providing crucial insights while developing and testing drugs. In this edition of Life Sciences Review Europe, we present the list of the Top 10 Bioanalytical Services Companies in Europe for the year 2022. GermanOncology GmbH is a prominent company that utilizes its extensive real-world database to assist physicians in devising effective treatment plans for patients through its analysis, consulting, project management, and IT development services. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs - Dave Henderson, CIO, Millennium Health; Stefano Ferrara, Director, Clinical Science, BeiGene, presenting their views and opinions on how organizations can incorporate changes in the bioanalytics industry. We hope the valuable insights from industry thought leaders and the bioanalytics agencies featured in this edition help you make informed decisions for your organization.Let us know your thoughts!EDITORIALTransforming Bioanalytical Services through Automated Laboratories and Relevant Data Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsOctober - 06 - 2022, Vol 03, Issue - 04 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersRonald DonovanVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
< Page 5 | Page 7 >